Podcasts about Disease

In this episode, Emily speaks with documentary filmmaker and journalist David France about his films How to Survive a Pandemic (2022) and How to Survive a Plague (2012), and the role of storytelling in documenting public health crises and holding institutions accountable. The Nocturnists is partnering with VCU Health Continuing Education to offer FREE CME credits for healthcare professionals. Visit ce.vcuhealth.org/nocturnists to claim credit for this episode. Find show notes, transcript, and more at thenocturnists.com.

Synopsis In the 19th century, the German spa town of Baden-Baden was the place to be in the summer. Wealthy international tourists could bathe in artesian wells by day, and by night, gamble at the casino or attend performances at a splendid theater modeled on the Paris Opera. That theater opened on today's date in 1862 with the premiere of a new comic opera by the French composer Hector Berlioz, based closely on Shakespeare's comedy ‘Much Ado About Nothing', and titled “Beatrice and Benedict” after the witty pair of lovers in the play. The composer himself conducted. “A great success,” Berlioz wrote the next day. “…applauded from beginning to end. I was recalled to the stage I don't know how many times.” Despite the success, Berlioz confessed, “My infernal neuralgia was so bad that I mounted the podium …without feeling the slightest emotion. This bizarre indifference meant I conducted better than usual!” Despite making light of his increasing illness, possibly Crohn's Disease, this opera proved to be his last work, and Berlioz had only a few more years to live. His biographer David Cairns writes: "Listening to the score's exuberant gaiety, only momentarily touched by sadness, one would never guess that its composer was in pain when he wrote it and impatient for death.” Music Played in Today's Program Hector Berlioz (1803–1869) –”Beatrice and Benedict” Overture (Boston Symphony; Charles Munch, cond.) RCA Victor Gold Seal 61400

 Discover how Couples Actually Sleep Better  Do ESSENTIAL OILS have any benefits for a Better Night's Sleep?  How much money do American's spend on Sleep Disorders!  Discover an All-Natural Sedative for Calming, Relaxing, Balancing, and a Sleep Aid  Are there any Suggested Oils for Sleep? Interested in NEW Transformational Health Program: Roadmap to Health and Longevity with 2 Coaches: Apply Here

Join Alejo (Greydawn95) and Aiden (Captain Chiral) as they discuss a few homebrew fixes to some systems in 5e. Originally streamed August 2nd, 2022 and available since August 5th, 2022 on the TableTalk: Discussion & Discourse YouTube Channel: https://www.youtube.com/channel/UCnTvDp6tbQ07bVEMFXYtp_g ***** Content covered in order: Why Diseases Do Nothing in D&D 5e (and how to fix them!) by Halfling Hobbies: https://youtu.be/vqytQ536dos Why Alchemy in D&D 5E is so TERRIBLE and how to FIX it by Luke's Homebrew: https://youtu.be/Yp2UsNm-pbk ***** Our Links: Our Website: https://www.tabletalkdandd.us/ Our Merch on TeePublic: http://tee.pub/lic/IRqBwaVQWhQ Support us on Patreon: https://www.patreon.com/TableTalkDnD Tabletop Alliance: https://tabletopalliance.org/ Support us and Tabletop Alliance on Humble Bundle through our Partner link: https://www.humblebundle.com/?partner=tabletalk&charity=4162172 Come join our Discord: https://discord.gg/tBt4MJ6 Follow the show on Twitter: https://twitter.com/TableTalkDandD Follow our Instagram: https://www.instagram.com/tabletalkdandd/ Send us and email: tabletalkdandd@gmail.com ***** Hosts: Alejo (Greydawn95) Aiden (Captain Chiral) Boo (PrinceBoo21) --- Send in a voice message: https://anchor.fm/tabletalkdandd/message

Curious about the Mediterranean Diet and impact on psoriatic disease? Dr. Adam Ford, UC Davis Health, Dept. of Dermatology and registered dietitian, Danielle Baham, Supportive Oncology & Survivorship, UC Davis Comprehensive Cancer Ctr, discuss evidence supporting use, and how changes lead to improved therapy response and reduce risk of related health conditions. This Psound Bytes episode is provided with support from AbbVie, Amgen, CeraVe, Bristol Myers Squibb, Janssen and Lilly. 

As with many medical conditions, people with Parkinson's disease (PD) may experience disparities in access to care, in diagnosis, treatments, and ancillary care. These disparities may be based on age, gender, race, financial situation, language barriers, and geographic location, among other factors. Dr. Lynda Nwabuobi, now a movement disorders specialist at New York-Presbyterian/Weill Cornell Parkinson's Disease and Movement Disorders Institute in New York City, received her specialized training at Columbia University, supported by a Parkinson's Foundation Movement Disorders Fellowship.   During her training, she noticed that women with PD who were home-bound were more likely than men to be alone and to have less access to a neurologist. She also recognized disparities in the care between the majority white population of people with PD seen at the main hospital clinic of New York University (NYU) compared to the more racially diverse, multicultural community of people seen at NYU's public Bellevue Hospital nearby – even though they were being treated by the same doctor. In this episode, she describes how she acted on her passion of “creating access to better care to marginalized communities and bring more diversity to the clinic.” Rather than waiting for the community to come to the health care setting, she reached out to them on their turf -- at a farmers' market.

Producer Lindsey presents a 2020 interview with Labor historian Tamara Fernando on disease and East Indian pearl fisheries, and what those early capitalist labor conditions in relation to diseases can tell us about the still-current moment.

In 2022, it is estimated that 6.5 million Americans are living with Alzheimer's disease.   The number of people per 100,000 newly diagnosed with Alzheimer's disease per year (incident rate) appears to be declining, the number of people with Alzheimer's disease (prevalence) is expected to continue to grow (2022 Alzheimer's Disease Facts and Figures Report, p. 19).     If you are or someone you love have been newly  diagnosed with Alzheimer's, this episode will give you 6 things to do because many people do not know where to start.  Many people feel that everything has changed after learning that a loved one has Alzheimer's disease or a related dementia. There are many myths and misperceptions about Alzheimer's disease (stigma) – this episode will give you resources to learn more about the reality of disease progression and steps to take.  First of all, remember that you're not alone. There is help available, and there are resources to connect you to people who understand what you've been through and what you're going to go through.  These six things presented in this podcast will help you after getting a diagnosis like Alzheimer's disease; tips on what to get organized, permission to make healthy living a priority, and ensuring important things are taken care of.  Key points covered in this episode:   ✔️ #1. Educate Yourself (And Others) About The Disease.  Being stigmatized by others is often a primary concern of people living with Alzheimer's and their care partners. Stigma is a negative label identifying a person with an illness or disability. Stigma around Alzheimer's disease typically happens because people don't understand it or know what to expect.   Learn as much as possible about this disease and encourage care partners to do the same. You can learn about the condition from the Alzheimer's Association website.  ✔️ #2. Coming To Terms With Your Diagnosis And Sharing The Diagnosis     With Others  You may or may not be able to come to terms with your diagnosis before you tell others. You may not want to wait until you've had time to come to terms with it, or you may want to wait; but either way,  as the disease progresses, you will need help and support from others who know and understand you. You can decide who to tell and when to tell and when you do, this is an excellent time to educate them, too.   ✔️ #3. Be An Active Participant In Your Financial, Legal, And Long-Term Care Planning.  This will likely be the best gift you can give your loved ones. If you don't provide information about your wishes and your legal documents accessible, the burden of making these decisions will fall on your loved ones. I recommend getting a copy of Cameron Huddleston's book “Mom & Dad, We Need to Talk” and filling out the “In Case of Emergency Organizer” available on her website for free.   ✔️ #4. Reevaluate Your Priorities.  Set goals for the things you still want to accomplish. Life is not over yet – so dust off that bucket list and start planning to do as much of it as possible while you're still able. This is the same thing that many people do after receiving a terminal diagnosis.   You know yourself best and what's most important to you in the time you have left – which by the way, could be 20 more years. While you are able, make decisions about how you want the rest of your life to look and share that vision with those who love you.  ✔️ #5. Take An Active Role In Managing Your Disease And Build Your Care Team.  Start now and begin to build your care team. This includes you, your family and friends, neighbors, and healthcare professionals with expertise in Alzheimer's care.   Learn more about Dementia Friendly Communities. These are communities that provide supportive options that foster quality of life. If you don't have one yet, you may want to look into starting one.   Additionally, find out if there is a Village in your area, join it and start volunteering. The Village Model is “neighbors caring for neighbors” – a nonprofit, grassroots, community-based organization of volunteers that reflects the needs of its members and communities.   ✔️ #6. Discuss Alternative Treatments, Supplements, And Medications With Your Healthcare Team.  Although current medications cannot cure Alzheimer's, some drugs may help lessen symptoms, such as memory loss and confusion, for a limited time. Other medicines change disease progression, with benefits to cognition and function.  Look into FDA-approved drugs, alternative treatments and supplements, and consider participating in clinical trials.   If you have questions, comments, or need help, please feel free to drop a one-minute audio or video clip and email it to me at melissabphd@gmail.com, and I will get back to you by recording an answer to your question.   About Melissa Batchelor, PhD, RN, FNP, FGSA, FAAN:   I earned my Bachelor of Science in Nursing ('96) and Master of Science in Nursing ('00) as a Family Nurse Practitioner (FNP) from the University of North Carolina Wilmington (UNCW) School of Nursing (SON). I genuinely enjoy working with the complex medical needs of older adults. I worked full-time for five years as FNP in geriatric primary care across many long-term care settings (skilled nursing homes, assisted living, home, and office visits), then transitioned into academic nursing in 2005, joining the faculty at UNCW SON as a lecturer. I obtained my PhD in Nursing and a post-master's Certificate in Nursing Education from the Medical University of South Carolina College of Nursing ('11). I then joined the faculty at Duke University School of Nursing as an Assistant Professor. My family moved to northern Virginia in 2015 which led to me joining the George Washington University (GW) School of Nursing faculty in 2018 as a (tenured) Associate Professor. I am also the Director of the GW Center for Aging, Health, and Humanities. Please find out more about her work at https://melissabphd.com/. 

Caleb Shomo of Beartooth joins to talk about Beartooth's new single "Riptide," recording "Disgusting," "Aggressive," and "Disease," co-writing with John Feldmann, Attack Attack and more. Sponsored by: DistroKid Follow Caleb Shomo on Instagram. Listen to Beartooth on Spotify. Follow The Punk Rock MBA on Twitter, Facebook, and YouTube. Follow Finn McKenty on Instagram and Twitch. PRMBA Merch Produced and edited by Deanna Chapman. Support The Punk Rock MBA on Patreon Learn more about your ad choices. Visit megaphone.fm/adchoices

Lyme disease, which is caused by bacteria spread by ticks, is very treatable when caught early. Learn the symptoms and how to prevent it in this episode of BrainStuff, based on this article: https://health.howstuffworks.com/diseases-conditions/infectious/lyme-disease.htmSee omnystudio.com/listener for privacy information.

Malpractice with Jennifer Wiggins – Body dysmorphic disorder with Dr. Toni Pikoos – Cosmetic recalls – Aplasia cutis and low risk of CNS disease Connect with Jennifer Wiggins and learn about malpractice: - aegismalpractice.com - Jennifer's podcast: https://podcasts.apple.com/us/podcast/malpractice-insights/id1579105507 Connect with Toni Pikoos and learn about body dysmorphic disorder: - https://foundationpsychology.com.au/melbourne_psychologists/toni-pikoos/ - Twitter: @tonipikoos - Instagram: https://www.instagram.com/thebddtherapist/?igshid=YmMyMTA2M2Y= Connect with us! - Web: https://dermaspherepodcast.com/ - Twitter: @DermaspherePC - Instagram: dermaspherepodcast - Facebook: https://www.facebook.com/DermaspherePodcast/ - Check out Luke and Michelle's other podcast, SkinCast! https://healthcare.utah.edu/dermatology/skincast/ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at: - Kikoxp.com(a social platform for doctors to share knowledge) - https://www.levelex.com/games/top-derm(A free dermatology game to learn more dermatology!)

The world of Alzheimer's research has recently been rocked by very strong evidence of scientific misconduct and fraud, specifically relating to a historically relevant paper about amyloid beta oligomers as a potential cause of Alzheimer's Disease. There are a lot of nuances and complexities at play here, which we dive into! There are also some... not-nuances, like the fact that this fraud and wholesale fabrication of results was pretty brazen. Listen in and learn more! References: https://www.nature.com/articles/nature04533 https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-disease

Learn about common peperomia diseases and easy disease management tips :)

Cancer.  The five letters, word and diagnosis that runs rampant through our healthcare system, and the one we dread hearing.  Ever.  This episode features Traci Trask-- a healthcare professional and breast cancer survivor.  Upon hearing her diagnosis, Traci relied heavily on research, second opinions and networking with other survivors to learn of their personal journeys and to both discover and advocate for the treatment that worked best for her and her lifestyle.  Traci's story is a heartfelt journey of self reflection, and this episode will give numerous examples and recommendations for others to self advocate for their own individual treatment plans.   In a society where we tend to rely on the traditional paths and status quo to tackling our illnesses, this episode will empower each listener to take their healthcare into their own hands.  Being brave, bold and empowered is what Traci teaches us all through her story.

Many of you remember me mentioning my mentor, Tony Saville. Well I have great news, we have him on the show. In fact, this episode is a conversation between Tony, my wife Nancy and myself, Kenny Troiano. Listen in as we talk about many topics concerning selection and breeding. We also talk about how Tony and me first met. Just know that Tony has always been a great teacher, who has had a great influence on me, and by listening in to this episode, I know he will have a great influence on you too. We specialize in the breeding of gamefowl and chickens, and other breeding related topics. This includes the proper use of breeding programs. Also, it's our mission to provide our members a greater understanding of poultry genetics, poultry health care and disease prevention, and how to improve the production and performance ability of their fowl. If you are interested in creating a strain, or improving your established strain, you are going to enjoy this show.  We also want to encourage you to join us at “The Breeders Academy,” where we will not only help you increase your knowledge of breeding, advance your skills as a breeder, but improve the quality and performance of your fowl. If you would like to learn more, start by joining our Breeders Bulletins (newsletter): https://www.breedersacademy.com/free_bonus/ #breedinggamefowl #breedingchickens #gamefowlbreeders #chickenbreeders #gamefowlbreeding #chickenbreeding #poultrygenetics #poultryhealth #gamefowlnation #backyardbreeders #breedersacademy #bredtoperfection #kennytroiano 

Skin aging is more than cosmetic. In addition to overall thinning, wrinkles, and pigmentary changes, skin becomes fragile and can bruise and tear more easily. In this, the first of three podcasts that address aging skin and improving skin health, board-certified dermatologists, Dr. Joel Schlessinger and Dr. Roger Ceilley discuss the characteristics and causes of aging skin, including an overview of options for intervention.

Roll over, Cujo! Stephen King's tale of a good dog gone bad packs more of an emotional impact than one might think. We're headed back to Castle Rock for Cujo!Listen to our Dead Zone episode here! Check out Danny and Zach's short film starring A Nightmare On Elm Street's Heather Langenkamp! COTTONMOUTHFor more How I Met Your Monster, visit us on our website and sign up for our newsletter! You'll get access to upcoming episodes and cool giveaways! HowIMetYourMonster.comLooking for How I Met Your Monster merch? Click here to check out the store! You'll also find 1000's of designs from independent artists!You can find all of our social media links on our Linktree! Linktr.ee/howimetyourmonsterFollow Zach, Danny, and Casey!For questions, comments, or other information, send us an email at zach@howimetyourmonster.com

SwineCast 1204 Show Notes: The Swine Disease Reporting System team chats with special guest Dr. Guilherme Cezar about new features and next steps for the Swine Disease Reporting System. They also review increased PEDV activity among the US states, and PRRSV activity in the US, looking at lineages and regional spikes. This SwineCast episode shares …

Pastor John Aldridge begins teaching on specific diseases and their spiritual roots.

Chapter 17:Upper Airway Disease to Small Animal Critical Care Medicine, 2e 2nd Edition by Deborah Silverstein DVM DACVECC, Kate Hopper BVSc MVSc DACVECC Host: Dr. Bobbi Conner Producer: Topher Conlan

Christopher M. Palmer, MD, received his medical degree from Washington University School of Medicine and completed his internship and psychiatry residency at McLean Hospital, Massachusetts General Hospital, and Harvard Medical School. He is currently the director of the Department of Postgraduate and Continuing Education at McLean Hospital and an assistant professor of psychiatry at Harvard Medical School. For over 20 years, Dr. Palmer's clinical work has focused on treatment resistant cases, and recently he has been pioneering the use of the ketogenic diet in psychiatry, especially treatment resistant cases of mood and psychotic disorders. You can find Dr. Palmer at https://www.chrispalmermd.com/, IG: https://www.instagram.com/chrispalmermd/, Twitter: https://twitter.com/ChrisPalmerMD/, Youtube: https://www.youtube.com/channel/UC_dTM-I4jnN5gHVyXkrCXcA/, and FB: https://www.facebook.com/ChrisPalmerMD/.  00:00 Introduction 02:52 Mental disorders as metabolic disorders of the brain 09:13 Insulin resistance and mental illness 12:23 Role of serotonin in mental health 17:25 Schizoaffective disorder, bipolar, and ketogenic diets 21:08 Diet and mental health 25:55 Metabolic labs for mental illness 31:12 Obesity and mental health disorders 33:30 Ketogenic diets and seizures, fasting, authophagy 35:38 Serum cholesterol, suicidality, violent crime 40:54 Alzheimer's disease and brain insulin resistance 44:50 Younger people getting diagnosed with mental disorders 47:26 Mental illness in society 52:46 Exogenous ketones See open positions at Revero: https://jobs.lever.co/Revero/ Join Carnivore Diet for a free 30 day trial: https://carnivore.diet/join/ Book a Carnivore Coach: https://carnivore.diet/book-a-coach/ Carnivore Shirts: https://merch.carnivore.diet Subscribe to our Newsletter: https://carnivore.diet/subscribe/ . ‪#revero #shawnbaker #Carnivorediet #MeatHeals #HealthCreation   #humanfood #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree  ‪

Jennifer Sucre, MD, is an Assistant Professor of Pediatrics and Cell and Developmental Biology at Vanderbilt University School of Medicine. She graduated from Harvard Medical School, trained in pediatrics at Washington University in St. Louis, and completed fellowship in Neonatal-Perinatal Medicine at UCLA. Since joining the Vanderbilt faculty in 2016, she has established a research program focused on understanding the molecular mechanisms of lung development and lung disease across the lifespan with a particular focus on developing novel 4D imaging approaches to study alveologenesis and on understanding molecular drivers of bronchopulmonary dysplasia, the leading complication in survivors of preterm birth. Her clinical experience treating premature infants provides a unique perspective for studying lung development, and she has cultivated new ex vivo, in vitro, and in vivo models of lung injury. Dr. Sucre has combined these models with single-cell biology and spatial transcriptomics to gain insights into cellular specialization and dynamics in the developing lung, elucidated age-regulated host susceptibility factors to SARS-CoV-2 infection, and defined previously unrecognized cell types in chronic respiratory diseases.Find out more about Jennifer and this episode at: www.the-incubator.org______________________________________________________________________________________As always, feel free to send us questions, comments or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through instagram or twitter, @nicupodcast. Or contact Ben and Daphna directly via their twitter profiles: @drnicu and @doctordaphnamd. enjoy!This podcast is proudly sponsored by Chiesi.

The best way to treat plant disease is to stop it from starting. We talk with an expert about keeping disease out of your garden.

One of the most important challenges facing Fatty Liver stakeholders involves improving early diagnosis for patients with clinically relevant or advanced fibrosis (F2/3). Today, a significant percentage of patients learn they are living with cirrhosis in the Emergency Department during a decompensating event. Four in ten of these patients in the UK do not leave the hospital. Episode 39 reviewed a model that Ian Rowe and Richard Parker developed to determine the most cost-effective strategy for F2/3 diagnosis.This conversation starts with Louise Campbell agreeing with the vision that led Ian and Richard to build this model. She notes recent data she heard that 85% of all US patients with cirrhosis (and 55% in the UK) learn their diagnoses for the first time in an Emergency Department, which suggests the need to improve earlier diagnosis. She notes that some UK programs are widely cited as examples of good (or best) practice, but, more important, notes that these have been cited as examples for a long time, but also notes that other regions and hospitals have not emulated them. She goes on to ask how the efficiency and number of patients captured in the model would increase if the target expanded to include all patients with metabolic disease. Ian notes that these patients were not included in the model and also suggests that the question reflects a larger question about the goal of this kind of screening.

Go online to PeerView.com/ZBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Treatment advances in metastatic melanoma have been characterized by the use of immunotherapy, including PD-1 and CTLA-4 checkpoint inhibitors, as well as targeted agents in BRAF-mutated disease—and collectively these modalities represent the driving forces leading to improved clinical outcomes across disease settings. How will new evidence change this current paradigm? In this MasterClass & Case Forum video activity, based on a live event at the 2022 ASCO Annual Meeting, an expert panel explores the latest practice-changing clinical evidence for managing BRAF-mutated melanoma, while providing case-based practical guidance on modern treatment decisions with immunotherapy and targeted agents. Learn how these experts are using novel immune-based options in this setting to improve outcomes for their patients with BRAF-mutated disease. Upon completion of this activity, participants should be better able to: Cite current evidence on the efficacy of modern sequential approaches to using immunotherapy and targeted regimens in the setting of BRAF-mutated, metastatic melanoma; Utilize optimized strategies with immunotherapy components for the initial and sequential management of patients with BRAF-mutated, metastatic melanoma; and Develop team-based, collaborative strategies for managing toxicity associated with the sequential use of immunotherapy and targeted agents in patients with metastatic melanoma.

Go online to PeerView.com/ZBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Treatment advances in metastatic melanoma have been characterized by the use of immunotherapy, including PD-1 and CTLA-4 checkpoint inhibitors, as well as targeted agents in BRAF-mutated disease—and collectively these modalities represent the driving forces leading to improved clinical outcomes across disease settings. How will new evidence change this current paradigm? In this MasterClass & Case Forum video activity, based on a live event at the 2022 ASCO Annual Meeting, an expert panel explores the latest practice-changing clinical evidence for managing BRAF-mutated melanoma, while providing case-based practical guidance on modern treatment decisions with immunotherapy and targeted agents. Learn how these experts are using novel immune-based options in this setting to improve outcomes for their patients with BRAF-mutated disease. Upon completion of this activity, participants should be better able to: Cite current evidence on the efficacy of modern sequential approaches to using immunotherapy and targeted regimens in the setting of BRAF-mutated, metastatic melanoma; Utilize optimized strategies with immunotherapy components for the initial and sequential management of patients with BRAF-mutated, metastatic melanoma; and Develop team-based, collaborative strategies for managing toxicity associated with the sequential use of immunotherapy and targeted agents in patients with metastatic melanoma.

Today on the Good Day Download:How one teen's quick thinking saved his neighbors from an apartment fire, an uptick in unauthorized needle jabs (read that again), a Legionnaires' disease outbreak in Napa and good news for John Legend and Chrissy Teigen. We discuss. Additional information available on GoodDayShow.com. Follow us on social media. Facebook & Instagram - @GoodDayRadioShowTwitter - @GoodDayOnAir

Go online to PeerView.com/NDA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

Dr. Lucilla Parnetti discusses the clinical application of α-synuclein seed amplification assays (SAAs) in the identification of Parkinson disease and other synucleinopathies.  Show references: https://n.neurology.org/content/99/5/195 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Go online to PeerView.com/ZBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Treatment advances in metastatic melanoma have been characterized by the use of immunotherapy, including PD-1 and CTLA-4 checkpoint inhibitors, as well as targeted agents in BRAF-mutated disease—and collectively these modalities represent the driving forces leading to improved clinical outcomes across disease settings. How will new evidence change this current paradigm? In this MasterClass & Case Forum video activity, based on a live event at the 2022 ASCO Annual Meeting, an expert panel explores the latest practice-changing clinical evidence for managing BRAF-mutated melanoma, while providing case-based practical guidance on modern treatment decisions with immunotherapy and targeted agents. Learn how these experts are using novel immune-based options in this setting to improve outcomes for their patients with BRAF-mutated disease. Upon completion of this activity, participants should be better able to: Cite current evidence on the efficacy of modern sequential approaches to using immunotherapy and targeted regimens in the setting of BRAF-mutated, metastatic melanoma; Utilize optimized strategies with immunotherapy components for the initial and sequential management of patients with BRAF-mutated, metastatic melanoma; and Develop team-based, collaborative strategies for managing toxicity associated with the sequential use of immunotherapy and targeted agents in patients with metastatic melanoma.

Go online to PeerView.com/NDA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Patients with severe asthma, uncontrolled symptoms, and exacerbations are at risk of losing lung function over time. Despite the availability of numerous treatments, many patients with severe asthma remain uncontrolled. Evolving insights into the pathophysiology of severe asthma have led to the development of biologic therapies that target epithelial alarmins, and their use is not restricted by phenotype/endotype or biomarkers. In this activity, based on a recent live web broadcast, our experts will review the latest clinical data, including key insights from medical congresses up to and including ATS 2022, with respect to novel and emerging therapies and other factors that impact the selection of treatment for patients with severe asthma who continue to have uncontrolled disease despite treatment. You will achieve greater insight into the most up-to-date evidence on the pathophysiology of severe asthma, particularly with regard to the role of epithelial alarmins in the development of severe asthma. Upon completion of this activity, participants should be better able to: Discuss the rationale for the use of therapeutic options that target epithelial alarmins, including TSLP, IL-33, and IL-25, for the treatment of severe asthma; Employ the latest pathophysiologic insights into the role of epithelial alarmins to the treatment of patients with severe asthma; and Develop treatment plans for patients with severe asthma, particularly those whose disease remains uncontrolled despite treatment, based on the latest clinical evidence with regard to novel and emerging therapies.

Go online to PeerView.com/NDA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you ready to make personalized treatment choices with the potent suite of targeted agents, including BTK and BCL-2 inhibitors, that have become standards of care in chronic lymphocytic leukemia (CLL)? In collaboration with the CLL Society, this PeerView MasterClass & Case Forum, based on a live event at the ASCO Annual Meeting, will give learners foundational insights on the evidence that supports the use of personalized therapy with modern targeted platforms. Watch the expert panel present a series of highly practical case discussions that include guidance on: the evidence-based selection of treatment strategies for treatment-naïve and relapsed CLL; therapeutic planning based on safety considerations; and the integration of novel combinatorial and cellular therapy strategies. Don't miss this expert-led program and receive CME/MOC credit! Upon completion of this activity, participants should be better able to: Summarize updated efficacy and safety evidence supporting the integration of novel therapeutic classes in CLL, including evidence with BTK, PI3K, and BCL-2 inhibitors, novel combinations, and CAR-T options; Recommend personalized treatment with targeted agents, including fixed duration or continuous therapy strategies or appropriate combinatorial or sequential options, for patients presenting with treatment-naïve or relapsed/refractory CLL; and Manage unique safety considerations associated with the use of targeted agents, novel antibodies, or cellular therapies in the CLL setting.

In The Memory of Colonialism in Britain and France: The Sins of Silence (Palgrave MacMillan, 2021), Itay Lotem explores the remembering of empire in Britain and France. By comparing these two former colonial powers, the author tells two distinct stories about coming to terms with the legacies of colonialism, the role of silence and the breaking thereof. Focusing on memory as an ongoing, politicized public debate, the book examines the afterlife of colonial history as an element of political and social discourse that depends on actors' goals and priorities. Itay Lotem earned his Ph.D at the University of London, Queen Mary and is currently a senior lecturer in French Studies at the University of Westminster. Michael G. Vann is a professor of world history at California State University, Sacramento. A specialist in imperialism and the Cold War in Southeast Asia, he is the author of The Great Hanoi Rat Hunt: Empires, Disease, and Modernity in French Colonial Vietnam (Oxford University Press, 2018). When he's not reading or talking about new books with smart people, Mike can be found surfing in Santa Cruz, California. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/intellectual-history

In The Memory of Colonialism in Britain and France: The Sins of Silence (Palgrave MacMillan, 2021), Itay Lotem explores the remembering of empire in Britain and France. By comparing these two former colonial powers, the author tells two distinct stories about coming to terms with the legacies of colonialism, the role of silence and the breaking thereof. Focusing on memory as an ongoing, politicized public debate, the book examines the afterlife of colonial history as an element of political and social discourse that depends on actors' goals and priorities. Itay Lotem earned his Ph.D at the University of London, Queen Mary and is currently a senior lecturer in French Studies at the University of Westminster. Michael G. Vann is a professor of world history at California State University, Sacramento. A specialist in imperialism and the Cold War in Southeast Asia, he is the author of The Great Hanoi Rat Hunt: Empires, Disease, and Modernity in French Colonial Vietnam (Oxford University Press, 2018). When he's not reading or talking about new books with smart people, Mike can be found surfing in Santa Cruz, California. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/critical-theory

In The Memory of Colonialism in Britain and France: The Sins of Silence (Palgrave MacMillan, 2021), Itay Lotem explores the remembering of empire in Britain and France. By comparing these two former colonial powers, the author tells two distinct stories about coming to terms with the legacies of colonialism, the role of silence and the breaking thereof. Focusing on memory as an ongoing, politicized public debate, the book examines the afterlife of colonial history as an element of political and social discourse that depends on actors' goals and priorities. Itay Lotem earned his Ph.D at the University of London, Queen Mary and is currently a senior lecturer in French Studies at the University of Westminster. Michael G. Vann is a professor of world history at California State University, Sacramento. A specialist in imperialism and the Cold War in Southeast Asia, he is the author of The Great Hanoi Rat Hunt: Empires, Disease, and Modernity in French Colonial Vietnam (Oxford University Press, 2018). When he's not reading or talking about new books with smart people, Mike can be found surfing in Santa Cruz, California. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/european-studies

In The Memory of Colonialism in Britain and France: The Sins of Silence (Palgrave MacMillan, 2021), Itay Lotem explores the remembering of empire in Britain and France. By comparing these two former colonial powers, the author tells two distinct stories about coming to terms with the legacies of colonialism, the role of silence and the breaking thereof. Focusing on memory as an ongoing, politicized public debate, the book examines the afterlife of colonial history as an element of political and social discourse that depends on actors' goals and priorities. Itay Lotem earned his Ph.D at the University of London, Queen Mary and is currently a senior lecturer in French Studies at the University of Westminster. Michael G. Vann is a professor of world history at California State University, Sacramento. A specialist in imperialism and the Cold War in Southeast Asia, he is the author of The Great Hanoi Rat Hunt: Empires, Disease, and Modernity in French Colonial Vietnam (Oxford University Press, 2018). When he's not reading or talking about new books with smart people, Mike can be found surfing in Santa Cruz, California. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In The Memory of Colonialism in Britain and France: The Sins of Silence (Palgrave MacMillan, 2021), Itay Lotem explores the remembering of empire in Britain and France. By comparing these two former colonial powers, the author tells two distinct stories about coming to terms with the legacies of colonialism, the role of silence and the breaking thereof. Focusing on memory as an ongoing, politicized public debate, the book examines the afterlife of colonial history as an element of political and social discourse that depends on actors' goals and priorities. Itay Lotem earned his Ph.D at the University of London, Queen Mary and is currently a senior lecturer in French Studies at the University of Westminster. Michael G. Vann is a professor of world history at California State University, Sacramento. A specialist in imperialism and the Cold War in Southeast Asia, he is the author of The Great Hanoi Rat Hunt: Empires, Disease, and Modernity in French Colonial Vietnam (Oxford University Press, 2018). When he's not reading or talking about new books with smart people, Mike can be found surfing in Santa Cruz, California. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

The best way to treat plant disease is to stop it from starting. We talk with an expert about keeping disease out of your garden.

Pre-Recorded WorkshopsLive WorkshopsDM Mitra what you felt about this episode